How much funding has ReCor Medical raised?

ReCor Medical has raised $25.4M in total funding, most recently a Series D round.

Who are ReCor Medical's investors?

ReCor Medical's investors include Otsuka Holdings, Sofinnova Partners.

Where is ReCor Medical headquartered?

ReCor Medical is headquartered in Palo Alto, California, United States.

What industry is ReCor Medical in?

ReCor Medical operates in Healthcare.

How many employees does ReCor Medical have?

ReCor Medical has 201-500 employees.

ReCor Medical

Acquired

Transforming hypertension management through ultrasound renal denervation

Palo Alto, United States · $25.4M raised

Healthcare

Headquarters: Palo Alto, California
Employees: 201–500
Business Model: B2B
Website: recormedical.com

Total Funding: $25.4M
Last Round: $15.0M Series DJun 2017
Rounds: 2

About

Recor Medical is a medical technology company focused on transforming the management of hypertension through its FDA-approved Paradise Ultrasound Renal Denervation (uRDN) system. The Paradise system uses 360-degree ultrasound energy to ablate renal nerves in 7-second treatment cycles, delivering clinically proven blood pressure reductions sustained across multiple years in patients with uncontrolled or resistant hypertension. As a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., Recor sells to interventional cardiologists and hospital catheterization labs in the United States and internationally, where the system also bears CE mark approval. The company has conducted multiple successful U.S. randomized controlled trials (RADIANCE-HTN series) and obtained a CMS National Coverage Determination, establishing a reimbursement pathway for routine clinical adoption.

Summary

ReCor Medical is a Healthcare company based in Palo Alto, United States. It has raised $25.4M in total across 2 rounds, most recently a $15.0M Series D round in Jun 2017. Investors include Otsuka Holdings and Sofinnova Partners.